Envista Holdings Corp
Research Envista Holdings Corp (NVST) on Bullrun: valuation model: 61.6% overvalued, market cap USD 4.40B, P/E 66.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNVST
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Valuation signal61.6% overvalued
- Market capUSD 4.40B
- P/E66.9
- Financial periodFY2025
- RevenueUSD 2.72B
- Revenue growth8.3%
- Net incomeUSD 47.00M
- Free cash flowUSD 230.40M
- Gross margin54.7%
Valuation Snapshot
Bullrun's latest valuation model marks Envista Holdings Corp as 61.6% overvalued; latest market cap is USD 4.40B; P/E is 66.9.
About Envista Holdings Corp
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist;
Frequently asked questions
Is Envista Holdings Corp overvalued or undervalued?
Bullrun's valuation model currently marks Envista Holdings Corp as 61.6% overvalued.
What is Envista Holdings Corp's market cap?
Envista Holdings Corp's market capitalization is USD 4.40B.
What is Envista Holdings Corp's P/E ratio?
Envista Holdings Corp's price-to-earnings (P/E) ratio is 66.9.
What does Envista Holdings Corp do?
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.